Actively Recruiting
Effects of Dual-Task Training on Upper Extremity Function and Muscle Thickness in Parkinson's Disease
Led by Ankara University · Updated on 2026-06-02
38
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
Sponsors
A
Ankara University
Lead Sponsor
H
Hacettepe University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how dual-task training affects upper extremity function and muscle thickness in people with Parkinson's disease. The study aims to find out if combining motor and cognitive tasks during training can improve arm and hand function and cause measurable changes in muscle thickness. This clinical trial compares this dual-task training to routine care to see if it provides greater benefits over 8 weeks. Participants will be randomly assigned to one of two groups. One group will receive dual-task training three times a week for 8 weeks, with each 60-minute session involving combined motor activities like peg placement and object manipulation alongside cognitive tasks such as backward counting and word generation. The control group will continue their usual daily activities without additional exercises or training during the study period. Participants will complete assessments before and after the 8-week intervention to measure upper extremity function, muscle thickness using ultrasonography, hand grip strength, and pinch strength. Researchers will monitor progress at baseline and week 8 to evaluate outcomes. The total study duration for each participant covers the 8-week training period and assessments before and after treatment.
CONDITIONS
Brief Title
Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
- Modified Hoehn and Yahr stage 2 to 3
- No medication or dosage change within the last 6 months
- Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score 61
- Voluntary participation with written informed consent
You will not qualify if you...
- Atypical or secondary parkinsonism
- Advanced orthopedic condition affecting the upper extremity
- Surgery, trauma, or immobilization involving the upper extremity within the last 6 months
- Wound or dermatological condition preventing upper extremity ultrasonographic evaluation
- Severe visual or hearing loss
- Severe depression, psychosis, or communication difficulty
- Any additional health problem preventing regular participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants in the training group perform dual-task training combining motor and cognitive tasks. Sessions occur three times per week for 8 weeks, with each session lasting 60 minutes. Participants in the control group continue their routine daily activities without additional intervention.
3 sessions per week, each lasting 60 minutes
Trial Site Locations
Total: 1 location
1
Hacettepe University
Ankara, Turkey (Türkiye)
Actively Recruiting
Research Team
B
Büşra Seçkinoğulları Korkusuz, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here